[Olanzapine in the first episode of schizophrenia in young adults].
The study concerns the therapeutic effectiveness of olanzapine in the treatment of the first episode of schizophrenia in children and young adults from the 12-19 year old age group. The positive symptoms were the first ones to cease. A constant rise in effectiveness was noted with time duration of application, especially in the case of negative symptoms. The treatment with olanzapine enabled most of the youngsters to continue school.
Dabkowska
Małgorzata
M
Katedra i Klinika Psychiatrii AM w Bydgoszczy.
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001569:Benzodiazepines; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine; D010890:Pirenzepine; D017367:Selective Serotonin Reuptake Inhibitors